Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators.

Zahra Bagheri-HosseinabadiAlireza DehghaniMohammad Amin LotfiMitra Abbasifard

Published in: Inflammopharmacology (2023)

It seems that Etanercept therapy in RA cases might increase proneness of the COVID-19 risk in these cases. The mechanism of this increased risk may stem from suppressing a protective immunity state in the RA cases.

Keyphrases

rheumatoid arthritis patients
coronavirus disease
disease activity
rheumatoid arthritis
ankylosing spondylitis
systemic lupus erythematosus
signaling pathway
sars cov
oxidative stress
juvenile idiopathic arthritis
mesenchymal stem cells
bone marrow